EE200100168A - Immunogeensed liposoomikompositsioonid - Google Patents
Immunogeensed liposoomikompositsioonidInfo
- Publication number
- EE200100168A EE200100168A EEP200100168A EEP200100168A EE200100168A EE 200100168 A EE200100168 A EE 200100168A EE P200100168 A EEP200100168 A EE P200100168A EE P200100168 A EEP200100168 A EE P200100168A EE 200100168 A EE200100168 A EE 200100168A
- Authority
- EE
- Estonia
- Prior art keywords
- liposome compositions
- immunogenic liposome
- immunogenic
- compositions
- liposome
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10135198P | 1998-09-22 | 1998-09-22 | |
| US40072399A | 1999-09-21 | 1999-09-21 | |
| PCT/US1999/020880 WO2000016746A2 (en) | 1998-09-22 | 1999-09-22 | Immunogenic liposome compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100168A true EE200100168A (et) | 2002-06-17 |
Family
ID=26798150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100168A EE200100168A (et) | 1998-09-22 | 1999-09-22 | Immunogeensed liposoomikompositsioonid |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1115382B1 (bg) |
| JP (1) | JP2002526436A (bg) |
| KR (1) | KR100592825B1 (bg) |
| CN (1) | CN1555254A (bg) |
| AP (1) | AP2010A (bg) |
| AT (1) | ATE468108T1 (bg) |
| AU (1) | AU766772B2 (bg) |
| BG (1) | BG65675B1 (bg) |
| BR (1) | BR9914004A (bg) |
| CA (1) | CA2344173C (bg) |
| CY (1) | CY1110718T1 (bg) |
| CZ (1) | CZ20011013A3 (bg) |
| DE (1) | DE69942393D1 (bg) |
| DK (1) | DK1115382T3 (bg) |
| EA (1) | EA004797B1 (bg) |
| EE (1) | EE200100168A (bg) |
| ES (1) | ES2345695T3 (bg) |
| GE (1) | GEP20053444B (bg) |
| HK (1) | HK1039064A1 (bg) |
| HU (1) | HUP0105391A3 (bg) |
| ID (1) | ID29082A (bg) |
| IL (2) | IL141675A0 (bg) |
| MX (1) | MXPA01002973A (bg) |
| NO (1) | NO330685B1 (bg) |
| NZ (2) | NZ528055A (bg) |
| OA (1) | OA11657A (bg) |
| PL (1) | PL206260B1 (bg) |
| SK (1) | SK287670B6 (bg) |
| UA (1) | UA75327C2 (bg) |
| WO (1) | WO2000016746A2 (bg) |
| ZA (1) | ZA200101829B (bg) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200726479A (en) | 2005-04-12 | 2007-07-16 | Univ Duke | Method of inducing neutralizing antibodies to human immunodeficiency virus |
| CN102448488B (zh) | 2009-06-04 | 2014-10-15 | 独立行政法人产业技术综合研究所 | 支原体感染症用疫苗 |
| CN103747797B (zh) * | 2011-04-26 | 2017-06-09 | 分子表达公司 | 脂质体制剂 |
| WO2015048635A1 (en) | 2013-09-27 | 2015-04-02 | Duke University | Mper-liposome conjugates and uses thereof |
| KR20190131116A (ko) * | 2017-04-04 | 2019-11-25 | 아비디아 테크놀로지스, 인크. | 펩티드-기반 백신, 그의 제조 방법, 및 면역 반응을 유도하기 위한 그의 용도 |
| KR20240033309A (ko) * | 2022-09-05 | 2024-03-12 | 주식회사 차백신연구소 | 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8405493D0 (sv) * | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| SE462375B (sv) * | 1985-10-15 | 1990-06-18 | Morgaardshammar Ab Centro | Traadblock |
| ES2032776T3 (es) * | 1986-05-20 | 1993-03-01 | Wako Pure Chemical Industries, Ltd. | Nuevos liposomas funcionalizados y un procedimiento para su produccion. |
| FR2754543B1 (fr) * | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
-
1999
- 1999-09-02 ID IDW20010900A patent/ID29082A/id unknown
- 1999-09-22 EP EP99969329A patent/EP1115382B1/en not_active Expired - Lifetime
- 1999-09-22 ES ES99969329T patent/ES2345695T3/es not_active Expired - Lifetime
- 1999-09-22 JP JP2000573707A patent/JP2002526436A/ja active Pending
- 1999-09-22 HU HU0105391A patent/HUP0105391A3/hu unknown
- 1999-09-22 DE DE69942393T patent/DE69942393D1/de not_active Expired - Lifetime
- 1999-09-22 NZ NZ528055A patent/NZ528055A/en not_active IP Right Cessation
- 1999-09-22 NZ NZ510442A patent/NZ510442A/en not_active IP Right Cessation
- 1999-09-22 MX MXPA01002973A patent/MXPA01002973A/es not_active IP Right Cessation
- 1999-09-22 CZ CZ20011013A patent/CZ20011013A3/cs unknown
- 1999-09-22 DK DK99969329.4T patent/DK1115382T3/da active
- 1999-09-22 UA UA2001031606A patent/UA75327C2/uk unknown
- 1999-09-22 WO PCT/US1999/020880 patent/WO2000016746A2/en active IP Right Grant
- 1999-09-22 KR KR1020017003621A patent/KR100592825B1/ko not_active IP Right Cessation
- 1999-09-22 EA EA200100269A patent/EA004797B1/ru not_active IP Right Cessation
- 1999-09-22 AT AT99969329T patent/ATE468108T1/de active
- 1999-09-22 AP APAP/P/2001/002096A patent/AP2010A/en active
- 1999-09-22 GE GE4350A patent/GEP20053444B/en unknown
- 1999-09-22 CA CA2344173A patent/CA2344173C/en not_active Expired - Fee Related
- 1999-09-22 OA OA1200100075A patent/OA11657A/en unknown
- 1999-09-22 IL IL14167599A patent/IL141675A0/xx active IP Right Revival
- 1999-09-22 CN CNA99811216XA patent/CN1555254A/zh active Pending
- 1999-09-22 AU AU60351/99A patent/AU766772B2/en not_active Ceased
- 1999-09-22 PL PL348604A patent/PL206260B1/pl not_active IP Right Cessation
- 1999-09-22 SK SK322-2001A patent/SK287670B6/sk not_active IP Right Cessation
- 1999-09-22 BR BR9914004-7A patent/BR9914004A/pt not_active IP Right Cessation
- 1999-09-22 EE EEP200100168A patent/EE200100168A/xx unknown
-
2001
- 2001-02-27 IL IL141675A patent/IL141675A/en not_active IP Right Cessation
- 2001-03-05 ZA ZA200101829A patent/ZA200101829B/en unknown
- 2001-03-20 NO NO20011406A patent/NO330685B1/no not_active IP Right Cessation
- 2001-03-22 BG BG105372A patent/BG65675B1/bg unknown
-
2002
- 2002-01-17 HK HK02100385.1A patent/HK1039064A1/xx not_active IP Right Cessation
-
2010
- 2010-07-30 CY CY20101100715T patent/CY1110718T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE339223T1 (de) | Kombinierte impfstoffzusammensetzungen | |
| NO20004758D0 (no) | Vaksinesammensetning | |
| ID26549A (id) | Komposisi-komposisi epotilon | |
| ATE367793T1 (de) | Schweisshemmende zusammensetzungen | |
| IS5555A (is) | Selekoxib lyfjablöndur | |
| ID30031A (id) | Formulasi-formulasi agrokimia | |
| ID23546A (id) | Formulasi-formulasi ziprasidon | |
| ID26926A (id) | Komposisi shampo pembentuk mode | |
| NO20004240D0 (no) | Formuleringer | |
| DE69900634D1 (de) | Shampoozusammensetzungen | |
| ATE224703T1 (de) | Brauseformulierungen | |
| ATE469550T1 (de) | Antiparasitäre zusammensetzungen | |
| DE69927758D1 (de) | Imidosilan-Zusammensetzungen | |
| DE69942892D1 (de) | Gaserzeugende zusammensetzung | |
| DE69928862D1 (de) | Zusammensetzung | |
| DK0974399T3 (da) | Rotordyse | |
| ID27889A (id) | Komposisi-komposisi kopolimer polisiklik | |
| ATE217021T1 (de) | Präparationsmittel | |
| EE200100168A (et) | Immunogeensed liposoomikompositsioonid | |
| NO20005483D0 (no) | Ny sammensetning | |
| IS5877A (is) | Ný efnablanda | |
| DE69939964D1 (de) | Gelförmige Zusammensetzung | |
| IS5879A (is) | Ný efnablanda | |
| ID23324A (id) | Komposisi fotostabil | |
| DE29805469U1 (de) | Peloidzubereitung |